Antipneumococcal Activity of BMS 284756 Compared to Those of Six Other Agents
AUTOR(ES)
Pankuch, Glenn A.
FONTE
American Society for Microbiology
RESUMO
Antipneumococcal activity of BMS 284756 was compared to those of six agents by MIC and time-kill methodologies. BMS 284756 had the lowest MICs compared to those of ciprofloxacin, levofloxacin, and moxifloxacin against quinolone-susceptible (≤0.016 to 0.06 μg/ml) and quinolone-resistant (0.03 to 1 μg/ml) pneumococci. BMS 284756 was bactericidal against 11 of 12 strains at two times the MIC after 24 h.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=126976Documentos Relacionados
- Antipneumococcal Activity of Ertapenem (MK-0826) Compared to Those of Other Agents
- Antipneumococcal Activity of ABT-773 Compared to Those of 10 Other Agents
- Antipneumococcal Activities of Gemifloxacin Compared to Those of Nine Other Agents
- In Vitro Activities of Garenoxacin (BMS-284756) against Streptococcus pneumoniae, Viridans Group Streptococci, and Enterococcus faecalis Compared to Those of Six Other Quinolones
- Antipneumococcal Activity of LBM415, a New Peptide Diformylase Inhibitor, Compared with Those of Other Agents
